Old Web
English
Sign In
Acemap
>
authorDetail
>
Jonas Schmidt
Jonas Schmidt
German Cancer Research Center
B-cell activating factor
Antibody
Belimumab
Medicine
Cell
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia.
2020
Cancers
Claudia Tandler
Moritz Schmidt
Jonas S Heitmann
Julia Hierold
Jonas Schmidt
Pascal Schneider
Daniela Dörfel
Juliane Walz
Helmut R. Salih
Show All
Source
Cite
Save
Citations (1)
Belimumab, a Neutralizing BAFF (B Cell Activating Factor) Antibody, Enhances the Susceptibility of Chronic Lymphoid Leukemia (CLL) Cells to Abt-199 Treatment
2015
Blood
Jonas Schmidt
Julia Wild
Benedikt Strunz
Lothar Kanz
Helmut R. Salih
Show All
Source
Cite
Save
Citations (1)
1